News

< Back

Grantee in the News: Beeson Scholar Dena Dubal Yields Big Results

On May 9, 2014 Cell Reports released the results of Dena Dubal, MD, PhD’s, study on a gene associated with long life and Lennart Mucke, MD, winner of a 2013 MetLife Foundation Award, administered by AFAR. This study was made possible in part by Dr. Dubal’s 2009 Paul Beeson Career Development Award from AFAR.

Dr. Dubal, Dr. Mucke and the rest of their team found that KL-VS, a variant of the KLOTHO gene already associated with longevity, helped carriers perform better on cognitive tests throughout their lifespan.

Additional tests performed on mice showed that KLOTHO strengthens the connections between neurons that make learning possible.

Researchers believe that high levels of KLOTHO may help delay the onset of Alzheimer’s and other diseases of cogitative decline.

Dena Dubal, MD, PhD, is an Assistant Professor of Neurology and the director of the Laboratory of Neuroscience and Aging Research at the University of California, San Francisco.

Lennart Mucke, MD, is a Professor of Neurology at the University of California, San Francisco School of Medicine.

Each year AFAR gives nearly $7 million dollars to promising investigators nationwide. For more information on the AFAR’s recently funded projects visit our List of Grantees page.

More Recent News

View All News >
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell